We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
-8.19%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$124M
AUM Growth
-$24.5M
Cap. Flow
+$12.1M
Cap. Flow %
9.79%
Top 10 Hldgs %
99.39%
Holding
11
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$11.5M
2
PCVX icon
Vaxcyte
PCVX
+$552K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCS icon
1
Oculis Holding
OCS
$721M
$43.8M 35.43%
2,300,774
+563,078
+32% +$11.5M
ARQT icon
2
Arcutis Biotherapeutics
ARQT
$3.27B
$33.2M 26.84%
2,120,508
– –
PCVX icon
3
Vaxcyte
PCVX
$8.9B
$26.8M 21.72%
710,734
+6,900
+1% +$552K
ZBIO
4
Zenas BioPharma
ZBIO
$1.99B
$5.82M 4.71%
736,645
– –
INZY
5
DELISTED
Inozyme Pharma
INZY
$4.09M 3.31%
4,494,851
– –
RXRX icon
6
Recursion Pharmaceuticals
RXRX
$1.76B
$3.15M 2.55%
595,518
– –
BIOA
7
BioAge Labs
BIOA
$487M
$2.46M 1.99%
653,374
– –
RLYB icon
8
Rallybio
RLYB
$86.7M
$1.56M 1.27%
300,581
– –
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
$998K 0.81%
560,595
– –
IOBT
10
DELISTED
IO Biotech
IOBT
$942K 0.76%
864,197
– –
BOLT icon
11
Bolt Biotherapeutics
BOLT
$6.49M
$757K 0.61%
94,573
– –

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q1 2025 Portfolio in Review

As of Q1 2025, Pivotal bioVenture Partners Investment Advisor held 11 positions worth $124M, down 17% from $148M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Pivotal bioVenture Partners Investment Advisor deployed $12.1M of net new capital in Q1 2025, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Pivotal bioVenture Partners Investment Advisor added most to Oculis Holding in Q1 2025, an estimated $11.5M increase.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 99% of its $124M portfolio in Q1 2025.
  • Pivotal bioVenture Partners Investment Advisor opened 0 new positions and closed 0 in Q1 2025.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value fell 17% quarter-over-quarter to $124M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q1 2025, filed 14 May 2025.